164 related articles for article (PubMed ID: 30344180)
1. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for an interventional randomised controlled trial.
China L; Skene SS; Bennett K; Shabir Z; Hamilton R; Bevan S; Chandler T; Maini AA; Becares N; Gilroy D; Forrest EH; O'Brien A
BMJ Open; 2018 Oct; 8(10):e023754. PubMed ID: 30344180
[TBL] [Abstract][Full Text] [Related]
2. ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.
China L; Muirhead N; Skene SS; Shabir Z; De Maeyer RP; Maini A; Gilroy DW; O'Brien AJ
BMJ Open; 2016 Jan; 6(1):e010132. PubMed ID: 26810999
[TBL] [Abstract][Full Text] [Related]
3. Administration of Albumin Solution Increases Serum Levels of Albumin in Patients With Chronic Liver Failure in a Single-Arm Feasibility Trial.
China L; Skene SS; Shabir Z; Maini A; Sylvestre Y; Bennett K; Bevan S; O'Beirne J; Forrest E; Portal J; Ryder S; Wright G; Gilroy DW; O'Brien A
Clin Gastroenterol Hepatol; 2018 May; 16(5):748-755.e6. PubMed ID: 28911947
[TBL] [Abstract][Full Text] [Related]
4. ASEPTIC: primary antibiotic prophylaxis using co-trimoxazole to prevent SpontanEous bacterial PeritoniTIs in Cirrhosis-study protocol for an interventional randomised controlled trial.
Crocombe D; Ahmed N; Balakrishnan I; Bordea E; Chau M; China L; Corless L; Danquah V; Dehbi HM; Dillon JF; Forrest EH; Freemantle N; Gear DP; Hollywood C; Hunter R; Jeyapalan T; Kallis Y; McPherson S; Munteanu I; Portal J; Richardson P; Ryder SD; Virk A; Wright G; O'Brien A
Trials; 2022 Sep; 23(1):812. PubMed ID: 36167573
[TBL] [Abstract][Full Text] [Related]
5. A Randomized Trial of Albumin Infusions in Hospitalized Patients with Cirrhosis.
China L; Freemantle N; Forrest E; Kallis Y; Ryder SD; Wright G; Portal AJ; Becares Salles N; Gilroy DW; O'Brien A;
N Engl J Med; 2021 Mar; 384(9):808-817. PubMed ID: 33657293
[TBL] [Abstract][Full Text] [Related]
6. Albumin Counteracts Immune-Suppressive Effects of Lipid Mediators in Patients With Advanced Liver Disease.
China L; Maini A; Skene SS; Shabir Z; Sylvestre Y; Colas RA; Ly L; Becares Salles N; Belloti V; Dalli J; Gilroy DW; O'Brien A
Clin Gastroenterol Hepatol; 2018 May; 16(5):738-747.e7. PubMed ID: 28859868
[TBL] [Abstract][Full Text] [Related]
7. Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).
Brennan PN; MacMillan M; Manship T; Moroni F; Glover A; Graham C; Semple S; Morris DM; Fraser AR; Pass C; McGowan NWA; Turner ML; Lachlan N; Dillon JF; Campbell JDM; Fallowfield JA; Forbes SJ
BMJ Open; 2021 Nov; 11(11):e053190. PubMed ID: 34750149
[TBL] [Abstract][Full Text] [Related]
8. Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.
Torp N; Israelsen M; Coenraad M; Papp M; Shawcross D; Korenjak M; Angeli P; Laleman W; Juanola A; Gines P; Trebicka J; Krag A;
BMJ Open; 2024 Feb; 14(2):e079309. PubMed ID: 38355195
[TBL] [Abstract][Full Text] [Related]
9. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
[TBL] [Abstract][Full Text] [Related]
10. Palliative long-term abdominal drains versus repeated drainage in individuals with untreatable ascites due to advanced cirrhosis: study protocol for a feasibility randomised controlled trial.
Macken L; Mason L; Evans C; Gage H; Jordan J; Austin M; Parnell N; Cooper M; Steer S; Boles J; Bremner S; Lambert D; Crook D; Earl G; Timeyin J; Verma S
Trials; 2018 Jul; 19(1):401. PubMed ID: 30053891
[TBL] [Abstract][Full Text] [Related]
11. PROFIT, a PROspective, randomised placebo controlled feasibility trial of Faecal mIcrobiota Transplantation in cirrhosis: study protocol for a single-blinded trial.
Woodhouse CA; Patel VC; Goldenberg S; Sanchez-Fueyo A; China L; O'Brien A; Flach C; Douiri A; Shawcross D
BMJ Open; 2019 Feb; 9(2):e023518. PubMed ID: 30772848
[TBL] [Abstract][Full Text] [Related]
12. Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial-a trial protocol.
Rombauts A; Abelenda-Alonso G; Simonetti AF; Verdejo G; Meije Y; Ortega L; Clemente M; Niubó J; Ruiz Y; Gudiol C; Tebé C; Videla S; Carratalà J
Trials; 2020 Aug; 21(1):727. PubMed ID: 32819439
[TBL] [Abstract][Full Text] [Related]
13. Integrated versus nOn-integrated Peripheral inTravenous catheter. Which Is the most effective systeM for peripheral intravenoUs catheter Management? (The OPTIMUM study): a randomised controlled trial protocol.
Castillo MI; Larsen E; Cooke M; Marsh NM; Wallis MC; Finucane J; Brown P; Mihala G; Carr PJ; Byrnes J; Walker R; Cable P; Zhang L; Sear C; Jackson G; Rowsome A; Ryan A; Humphries JC; Sivyer S; Flanigan K; Rickard CM
BMJ Open; 2018 May; 8(5):e019916. PubMed ID: 29764876
[TBL] [Abstract][Full Text] [Related]
14. Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial.
China L; Tittanegro T; Crocombe D; Forrest E; Kallis Y; Ryder SD; Wright G; Freemantle N; O'Brien A
EClinicalMedicine; 2023 Apr; 58():101924. PubMed ID: 37090442
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of intravenous albumin therapy to prevent spontaneous bacterial peritonitis, renal dysfunction and death in adults with cirrhosis: a protocol for a systematic review.
Härmälä S; Parisinos C; Ryan J; O'Brien A
BMJ Open; 2019 Jan; 9(1):e025664. PubMed ID: 30700489
[TBL] [Abstract][Full Text] [Related]
16. Trial summary and protocol for a phase II randomised placebo-controlled double-blinded trial of Interleukin 1 blockade in Acute Severe Colitis: the IASO trial.
Thomas MG; Bayliss C; Bond S; Dowling F; Galea J; Jairath V; Lamb C; Probert C; Timperley-Preece E; Watson A; Whitehead L; Williams JG; Parkes M; Kaser A; Raine T
BMJ Open; 2019 Feb; 9(2):e023765. PubMed ID: 30772849
[TBL] [Abstract][Full Text] [Related]
17. Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial.
Thévenot T; Bureau C; Oberti F; Anty R; Louvet A; Plessier A; Rudler M; Heurgué-Berlot A; Rosa I; Talbodec N; Dao T; Ozenne V; Carbonell N; Causse X; Goria O; Minello A; De Ledinghen V; Amathieu R; Barraud H; Nguyen-Khac E; Becker C; Paupard T; Botta-Fridlung D; Abdelli N; Guillemot F; Monnet E; Di Martino V
J Hepatol; 2015 Apr; 62(4):822-30. PubMed ID: 25463545
[TBL] [Abstract][Full Text] [Related]
18. Targeted Albumin Infusions Do Not Improve Systemic Inflammation or Cardiovascular Function in Decompensated Cirrhosis.
China L; Becares N; Rhead C; Tittanegro T; Freemantle N; O'Brien A
Clin Transl Gastroenterol; 2022 May; 13(5):e00476. PubMed ID: 35333783
[TBL] [Abstract][Full Text] [Related]
19. Securing All intraVenous devices Effectively in hospitalised patients--the SAVE trial: study protocol for a multicentre randomised controlled trial.
Rickard CM; Marsh N; Webster J; Playford EG; McGrail MR; Larsen E; Keogh S; McMillan D; Whitty JA; Choudhury MA; Dunster KR; Reynolds H; Marshall A; Crilly J; Young J; Thom O; Gowardman J; Corley A; Fraser JF
BMJ Open; 2015 Sep; 5(9):e008689. PubMed ID: 26399574
[TBL] [Abstract][Full Text] [Related]
20. Randomised, open-label, multicentre trial comparing haemodialysis plus haemoperfusion versus haemodialysis alone in adult patients with end-stage renal disease (HD/HP vs HD): study protocol.
Lu W; Jiang GR;
BMJ Open; 2018 Jul; 8(7):e022169. PubMed ID: 30056391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
